Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
| Gene | Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|---|
grlA topoisomerase IV subunit A | N327K | - | mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones | Staphylococcus aureus | ciprofloxacinlevofloxacinmoxifloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | P157L | - | mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones | Staphylococcus aureus | ciprofloxacinlevofloxacinmoxifloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | P451L | - | - | - | ciprofloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | P451S | - | mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones | Staphylococcus aureus | ciprofloxacinlevofloxacinmoxifloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | R43C | - | mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones | Staphylococcus aureus | ciprofloxacinlevofloxacinmoxifloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | R85Q | - | - | - | ciprofloxacin | Reslit | Candidate |
grlA DNA topoisomerase IV subunit A | S143P | - | - | Staphylococcus aureus | ciprofloxacin | Reslit | Candidate |
grlA DNA gyrase subunit A | S144P | - | - | - | ciprofloxacin | Reslit | Candidate |
grlA topoisomerase IV subunit A | S52R | - | mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones | Staphylococcus aureus | ciprofloxacinlevofloxacinmoxifloxacin | Reslit | Candidate |
| S80F | reduced the potency of ciprofloxacin, mutations in grlA (Ser80→Phe or Tyr) were most commonly selected with trovafloxacin, ciprofloxacin, levofloxacin, or pefloxacin, resistance, confers resistance to fluoroquinolones, mutations result in the synthesis of proteins with reduced susceptibility or insensitivity to fluoroquinolones, Target modification | Staphylococcus aureus, Streptococcus pneumoniae, S. epidermidis, S. haemolyticus, S. arlettae, S. simulans, S. saprophyticus, S. borealis, S. sciuri, S. hominis, S. pasteuri, S. hyicus | quinolonesciprofloxacinfluoroquinolones+10 more | ResFinder DatabaseReslit | Confirmed |
Page 350 of 1344 (13,437 results)